LivaNova Announces 2021 Virtual Investor Day

Company leadership to present long-range business plan, along with overviews on franchises and strategic pipeline initiatives

LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it will host a virtual Investor Day on December 7 from 8 a.m.–12 p.m. Central Time (9 a.m.–1 p.m. Eastern Time). Executive leadership will share the LivaNova long-range business plan to maximize growth and shareholder value. Senior leadership, accompanied by key opinion leader clinicians, will provide overviews on the Company’s franchises and strategic pipeline initiatives. The leadership team will also be available for Q&A sessions.

LivaNova will host a live webcast of the event. All those interested in attending can register via the LivaNova website. A replay and all presentation materials will be posted immediately following the event in the Investors section of the LivaNova website and will remain available for one year.

About LivaNova

LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through innovative medical technologies, delivering life-changing improvements for both the Head and Heart. Headquartered in London, LivaNova employs approximately 3,000 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals and healthcare systems worldwide. For more information, please visit www.livanova.com.

Safe Harbor Statement

This news release contains “forward-looking statements” concerning our goals, beliefs, expectations, strategies, objectives, plans and underlying assumptions and other statements that are not necessarily based on historical facts. These statements include, but are not limited to, statements regarding participation in upcoming events. Actual results may differ materially from those indicated in our forward-looking statements as a result of various factors, including those factors set forth in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2020, as supplemented by any risk factors contained in our Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K. We undertake no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances.